530057 VIVANZA

Vivanza Biosciences Share Price Vivanza Biosciences

₹6.54
-0.01 (-0.15%)
14 May, 2024 01:03 BSE: 530057 NSE: VIVANZAISIN: INE984E01035

Start SIP in Vivanza Biosciences

Start SIP

Vivanza Biosciences Performance

Day Range

  • Low 0
  • High 0
₹ 6

52 Week Range

  • Low 0
  • High 0
₹ 6
  • Open Price0
  • Previous Close0
  • Volume

Vivanza Biosciences Share Price

  • Over 1 Month -27.49%
  • Over 3 Month -25.6%
  • Over 6 Month -36.01%
  • Over 1 Year -57.34%

Vivanza Biosciences Key Statistics

Vivanza Biosciences Financials
IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 23456
Operating Expenses Qtr Cr 23446
Operating Profit Qtr Cr 00000
Depreciation Qtr Cr 00000
Interest Qtr Cr 00000
Tax Qtr Cr 00000
Net Profit Qtr Cr 00000
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 1415
Operating Expenses Annual Cr 1413
Operating Profit Annual in Cr 11
Depreciation Cr 00
Interest Annual Cr 00
Tax Annual Cr 00
Net Profit Annual Cr 01
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 20
Cash from Investing Activity Annual Cr 0
Cash from Financing Annual Activity Cr -20
Net Cash Flow Annual Cr 0
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 54
Fixed Assets Annual Cr 00
Total Non Current Assets Annual Cr 33
Total Current Assets Annual Cr 1418
Total Assets Annual Cr 1720
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 11
ROE Annual % 713
ROCE Annual % 1525
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 68
IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 47898
Operating Expenses Qtr Cr 56798
Operating Profit Qtr Cr 00010
Depreciation Qtr Cr 00000
Interest Qtr Cr 00000
Tax Qtr Cr 00000
Net Profit Qtr Cr 00000
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 2818
Operating Expenses Annual Cr 2717
Operating Profit Annual in Cr 11
Depreciation Cr 00
Interest Annual Cr 00
Tax Annual Cr 00
Net Profit Annual Cr 11
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 2-1
Cash from Investing Activity Annual Cr 0
Cash from Financing Annual Activity Cr -21
Net Cash Flow Annual Cr 0
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 54
Fixed Assets Annual Cr 21
Total Non Current Assets Annual Cr 43
Total Current Assets Annual Cr 1620
Total Assets Annual Cr 2022
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 11
ROE Annual % 1215
ROCE Annual % 1521
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 46

Vivanza Biosciences Technicals

EMA & SMA

Current Price
₹6.54
-0.01 (-0.15%)
pointer
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • ₹7.46
  • 50 Day
  • ₹7.74
  • 100 Day
  • ₹8.33
  • 200 Day
  • ₹9.49
  • 20 Day
  • ₹7.81
  • 50 Day
  • ₹7.56
  • 100 Day
  • ₹8.34
  • 200 Day
  • ₹9.84

Vivanza Biosciences Resistance and Support

PIVOT
₹6.49
Resistance
First Resistance 6.62
Second Resistance 6.72
Third Resistance 6.85
RSI 30.80
MFI 7.18
MACD Single Line -0.10
MACD -0.30
Support
First Resistance 6.39
Second Resistance 6.26
Third Resistance 6.16

Vivanza Biosciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 56,488 5,648,800 100
Week 149,400 14,940,000 100
1 Month 277,367 23,149,010 83.46
6 Month 247,944 21,097,526 85.09

Vivanza Biosciences Result Highlights

Vivanza Biosciences Synopsis

Market Cap
Sales
Shares in Float
No of funds
Yield
Book Value
U/D Vol ratio
LTDebt / Equity
Alpha
Beta

Vivanza Biosciences

Owner NameMar-24Dec-23Sep-23Jun-23
Promoters 43.24%44.9%47.29%47.8%
Financial Institutions/ Banks
Individual Investors 13.82%9.05%6.23%5.66%
Others 42.94%46.05%46.48%46.54%

Vivanza Biosciences Management

Name Designation
Mr. Mehta J A Managing Director
Ms. A S Vyas Independent Woman Director
Mr. Parikh H A Director
Mr. Shah S D Independent Director

Vivanza Biosciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Vivanza Biosciences Corporate Action

Date Purpose Remarks
2024-04-30 Audited Results
2024-02-06 Quarterly Results
2023-10-26 Quarterly Results
2023-08-10 Quarterly Results
2023-06-30 A.G.M. Inter alia, to consider and approve the Directors Report and Secretarial Audit Report along with annexure for the Financial Year 2022-23. split from Rs. 10/- to Re. 1/-.
Date Purpose Remarks
2023-03-24 Split Rs.0.00 split from Rs. 10/- to Re. 1/-.

Vivanza Biosciences MF Shareholding

Name Amount(cr)

Vivanza Biosciences FAQs

What is Share Price of Vivanza Biosciences ?

Vivanza Biosciences share price is ₹6 As on 14 May, 2024 | 00:50

What is the Market Cap of Vivanza Biosciences ?

The Market Cap of Vivanza Biosciences is ₹26.2 Cr As on 14 May, 2024 | 00:50

What is the P/E ratio of Vivanza Biosciences ?

The P/E ratio of Vivanza Biosciences is 47.8 As on 14 May, 2024 | 00:50

What is the PB ratio of Vivanza Biosciences ?

The PB ratio of Vivanza Biosciences is 5.6 As on 14 May, 2024 | 00:50

Q2FY23